Recognition of galactan components of pectin by galectin-3

Institute of Food Research, Norwich Research Park, Colney, Norwich NR4 7UA, UK.
The FASEB Journal (Impact Factor: 5.48). 11/2008; 23(2):415-24. DOI: 10.1096/fj.08-106617
Source: PubMed

ABSTRACT It has been reported that modified forms of pectin possess anticancer activity. To account for this bioactivity, it has been proposed that fragments of pectin molecules can act by binding to and inhibiting the various roles of the mammalian protein galectin 3 (Gal3) in cancer progression and metastasis. Despite this clear molecular hypothesis and evidence for the bioactivity of modified pectin, the structural origins of the "bioactive fragments" of pectin molecules are currently ill defined. By using a combination of fluorescence microscopy, flow cytometry, and force spectroscopy, it has been possible to demonstrate, for the first time, specific binding of a pectin galactan to the recombinant form of human Gal3. Present studies suggest that bioactivity resides in the neutral sugar side chains of pectin polysaccharides and that these components could be isolated and modified to optimize bioactivity.

Download full-text


Available from: Roy Bongaerts, Jul 28, 2015
  • Source
    • "Gunning et al. (2013) confirmed that neutral galactan side chains did selectively bind to recombinant galectin-3. These active fragments can be obtained by enzymatic treatment of isolated RG-I regions from potato pectin (Gunning et al., 2009). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Despite enormous efforts that have been made in the search for novel drugs and treatments, cancer continues to be a major public health problem. Moreover, the emergence of resistance to cancer chemotherapy often prevents complete remission. Researchers have thus turned to natural products mainly from plant origin to circumvent resistance. Pectin and pH- or heat-modified pectin have demonstrated chemopreventive and antitumoral activities against some aggressive and recurrent cancers. The focus of this review is to describe how pectin and modified pectin display these activities and what are the possible underlying mechanisms. The failure of conventional chemotherapy to reduce mortality as well as serious side effects make natural products, such as pectin-derived products, ideal candidates for exerting synergism in combination with conventional anticancer drugs.
    Frontiers in Pharmacology 10/2013; 4:128. DOI:10.3389/fphar.2013.00128 · 3.80 Impact Factor
  • Source
    • "Their sugar composition was correlated with their capacity to inhibit Gal - 3 . Pectins with high arabinose and galactose contents , representing polymeric arabi - nogalactan side chains , were active . Our okra pectin has a rather different structure and therefore seems to rep - resent another category of active pectic molecules . Gunning et al . ( 2009 ) used physical analyses to demon - strate the specifi c binding of a pectin galactan to the recombinant form of human Gal - 3 . They suggest that the bioactivity of pectin polysaccharides resides in the neutral sugar side chains . We therefore postulate that okra pectin , which contains an almost pure RG - I carry - ing short galactan "
    [Show abstract] [Hide abstract]
    ABSTRACT: The proliferation and apoptosis of metastatic melanoma cells are often abnormal. We have evaluated the action of a pectic rhamnogalacturonan obtained by hot buffer extraction of okra pods (okra RG-I) on melanoma cell growth and survival in vitro. We added okra RG-I containing an almost pure RG-I carrying very short galactan side chains to 2D (on tissue culture polystyrene, tPS) and 3D (on poly(2-hydroxyethylmethacrylate), polyHEMA) cultures of highly metastatic B16F10 mouse melanoma cells. We then analyzed cell morphology, proliferation index, apoptosis, cell cycle progression and the expression of adhesion molecules. Immunostaining and western blotting were used to assay galectin-3 (Gal-3) protein.Incubation with okra RG-I altered the morphology of B16F10 cells and significantly reduced their proliferation on both tPS and polyHEMA. The cell cycle was arrested in G2/M, and apoptosis was induced, particularly in cells on polyHEMA. The expression of N-cadherin and alpha5 integrin subunit was reduced and that of the multifunctional carbohydrate-binding protein, Gal-3, at the cell membrane increased.These findings suggest that okra RG-I induces apoptosis in melanoma cells by interacting with Gal-3. As these interactions might open the way to new melanoma therapies, the next step will be to determine just how they occur.
    Phytotherapy Research 12/2009; 24(7):982-9. DOI:10.1002/ptr.3040 · 2.40 Impact Factor
  • Komplementäre und Integrative Medizin 04/2009; 50(4). DOI:10.1016/
Show more